Iridius Raises $8.6M to Build AI Platform for Compliance

The company plans to use the funds to grow its operations and continue developing its products.

Iridius is creating a new type of enterprise system that embeds compliance directly into AI via executable rules, enabling it to follow regulations and generate proof at every stage automatically. It works alongside existing enterprise systems and AI platforms rather than replacing them. This helps highly regulated companies speed up their workflows, reduce the effort needed for checks and validation, and stay ready for audits at all times, making it easier to improve and redesign business processes with AI.

Life sciences organizations are spending a lot on AI, but it often fails in the most important workflows. The problem is not how well the AI models perform, but how they are used in strict, regulated environments. Compliance is still handled manually and checked only after work is completed, while workflows are scattered and governance is not well-connected. Most AI platforms were not built for this situation, so they struggle to meet the strict requirements of GxP environments.

Read More:Google Plans to Invest Up to $40 Billion in Anthropic

“AI is not failing because of its capability. Its failing to scale because compliance is not built into how systems operate, said Mike Kropp CEO of Iridius. “We are building the infrastructure that makes AI deployable in regulated environments. By turning compliance into executable logic, and embedding it directly into workflows, we enable enterprises to move faster reduce risk, and take Artificial intelligence (AI) into production.”

“In life sciences, it’s one thing to prove a concept and another to make it work in production under real regulatory constraints. That’s where most efforts fall. What stood out about Iridius is the team’s experience building and shipping enterprise systems at scale, and their view of compliance not as overhead, but as something embedded into execution that becomes a real advantage,” said Clark Golestani, former President and CIO at Merck and Founder of K2 Access Fund.

“When I met the Iridius team, it was immediately clear this wasn’t a typical seed-stage startup. CEO Mike Kropp arrived with six senior enterprise leaders. Their deep enterprise experience is matched by operational rigor and AI-native speed. The group works hard, holds itself to high standards, and takes enterprise customers seriously. It’s no surprise that Accenture, along with an advisory board of former pharma and life sciences CIOs, has joined me in backing Mike, Alistair, Mark, Spencer, and the exceptional Iridius team,” said Mike Chalfen, Founder of Chalfen Ventures.

“As AI compresses traditional sources of software differentiation, the advantage is shifting toward systems that can operate within real-world constraints like GxP compliance. In life sciences, that constraint has historically limited innovation and slowed adoption. Iridius is re-architecting this layer by making compliance native to execution, which we believe is critical to moving AI from pilot to production in regulated environments,” said Nate Lentz, Managing Partner at Osage Venture Partners.

“Our investment in Iridius is about giving life sciences organizations the ability to innovate without hesitation, said Ray Pressburger, global life sciences lead at Accenture. “By embedding compliance into the core of AI, we are helping accelerate clinical development, improve decision making and bring therapies to patients faster all while meeting the rigorous expectations of regulators worldwide.”

About Iridius

Founded in 2024, by Mike Kropp, Alistair Lowe Norris and Mark Turley Iridius is an Artificial intelligence (AI) platform built with compliance at its core helping companies design build and run AI systems that always follow regulations. It turns complex regulatory rules into clear executable logic. It integrates them directly into workflows automatically enforcing compliance and generating proof in real time, making it easier to scale AI in highly regulated environments.

Read More:Intrepid Capital Appoints Nick Elias As Head of Investor Relations